Anne-Maree EnglundPolicy Manager
The Australian Medical Technology and Pharmaceutical (MTP) sector is acknowledged as a world leader in the MTP sector due to its vibrant research environment, supporting over 62,000 jobs, over 1,230 companies, and generating $4.9 billion gross value added to the Australian economy in 2016. However it has a poor track record in commercialisation. QUT is therefore partnering with 15 of the world’s largest pharmaceutical companies and Australia’s MTPConnect’s Industry Growth Centre to co-create The Bridge Program. This exciting new initiative is connecting global expertise with Australian entrepreneurs, industry professionals, research scientists and business developers to generate commercial outputs from Australian pharmaceutical research. The first cohort of 101 participants completed the Bridge Program in 2017 and a second cohort has commenced in 2018. This session explores the best frameworks and components that universities and businesses alike can use to foster effective partnerships and commercialisation of research.
- Blend high-level didactic delivery, immersive and experiential learning design, and network facilitation used to drive participant connection
- Establish an open dialogue between researchers and industry, create meaningful networks, and cultivate an entrepreneurial mindset
- Engaging partners in co-creation of the learning experience, and in skills experience sessions with participants to provide advice and practice in developing the knowledge and skills to interact effectively with industry representatives.
- Assessing best practice and lessons learned from QUT’s implementation of The Bridge Program